Neos Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, NEOS, Neos Therapeutics Inc, priceseries

Neos Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
1.16
Close
1.15
High
1.18
Low
1.06
Previous Close
1.18
Daily Price Gain
-0.03
YTD High
1.68
YTD High Date
Mar 18, 2021
YTD Low
0.61
YTD Low Date
Jan 4, 2021
YTD Price Change
0.51
YTD Gain
78.85%
52 Week High
1.68
52 Week High Date
Mar 18, 2021
52 Week Low
0.61
52 Week Low Date
Jan 4, 2021
52 Week Price Change
0.46
52 Week Gain
66.18%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 6. 2017
6.15
Mar 21. 2017
6.87
11 Trading Days
11.76%
Link
LONG
Aug 21. 2017
6.90
Sep 18. 2017
8.56
19 Trading Days
24.06%
Link
LONG
Dec 10. 2018
2.11
Dec 11. 2018
2.30
1 Trading Days
9.24%
Link
LONG
Mar 13. 2019
2.22
Mar 25. 2019
2.76
8 Trading Days
24.44%
Link
LONG
Jun 28. 2019
1.29
Jul 15. 2019
1.44
10 Trading Days
11.67%
Link
LONG
Aug 7. 2019
1.46
Sep 3. 2019
1.87
18 Trading Days
28.26%
Link
LONG
Jan 13. 2020
1.43
Jan 30. 2020
1.65
12 Trading Days
15.42%
Link
LONG
Feb 3. 2021
0.86
Feb 18. 2021
1.02
10 Trading Days
19.70%
Link
Company Information
Stock Symbol
NEOS
Exchange
NasdaqGM
Company URL
http://www.neostx.com
Company Phone
972.408.1360
CEO
Vipin K. Garg
Headquarters
Texas
Business Address
2940 N. HIGHWAY 360, SUITE 400, GRAND PRAIRIE, TX 75050
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001467652
About

Neos Therapeutics, Inc. operates as a pharmaceutical company, which engages in developing, manufacturing, and commercializing products using proprietary, extended-release drug delivery technology platform. It uses this technology to develop products for the treatment of attention deficit hyperactivity disorder (ADHD), including an extended-release orally disintegrating tablet. The company was founded on June 15, 2009 and is headquartered in Grand Prairie, TX.

Description

Neos Therapeutics, Inc., a pharmaceutical company, engages in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. Its product candidates are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough and upper respiratory symptoms associated with allergies or colds in adults and children of six years of age and older. Its product candidates include Adzenys XR-ODT amphetamine for the treatment of ADHD; Cotempla XR-ODT methylphenidate for the treatment of ADHD; and NT-0201 amphetamine XR liquid suspension for the treatment of ADHD. The company is headquartered in Grand Prairie, Texas.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading